Morgan Stanley Sees No Catalyst for Medtronic to Narrow the Discount vs. Peers
February 19, 2014 at 08:19 AM EST
In a report published Wednesday, Morgan Stanley analyst David R. Lewis reiterated an Equal-Weight rating on Medtronic (NYSE: MDT ). In the report, Morgan Stanley noted, “The quarter confirmed fears on CRM share loss and EM pressure, but both were roughly inline with expectations. Concerns notwithstanding, the key issue for